Circulation
A recently published study indicated that in REDUCE-IT patients with a history of CABG, Icosapent Ethyl treatment was associated with a significant reduction in first and recurrent ischemic events.
The Lancet: Diabetes and Endocrinology
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
The annals of internal medicine
A large-scale, population-based, retrospective cohort study assessed the frequency of intensification by adding a new medication versus maximizing dose
Diabetologia
Diabetes and the risk of hospitalization for infection: the Atherosclerosis Risk in Communities (ARIC) study
FDA
FDA Authorized COVID-19 Vaccine for Emergency Use Children 5-11
Journal of the American College of Cardiology
AHA/ACC publishes comprehensive guidance on chest pain
Last month, we successfully delivered our very first hybrid event to in-person attendees and virtual participants from across the country.
Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700
Unsubscribe Manage preferences
